Crossmark

Synthesis, molecular docking, and in-vitro studies of pyrimidine-2-thione derivatives as antineoplastic agents via potential RAS/PI3K/Akt/JNK inhibition in breast carcinoma cells

Crossref DOI link: https://doi.org/10.1038/s41598-022-26571-7

Published Online: 2022-12-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salem, Maha M.

Gerges, Marian N.

Noser, Ahmed A.
Funding

Funding for this research was provided by:

Tanta University
License Information

Text and Data Mining valid from 2022-12-22

Version of Record valid from 2022-12-22
More Information

Article History

Received: 17 September 2022

Accepted: 16 December 2022

First Online: 22 December 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below